Y ellow nail syndrome (YNS) is a rare disease of unknown etiology (1) . Th e term YNS was fi rst described by Samman and White in 1964 (2) . Th ey reported a group of 13 patients with lymphedema of the lower extremities and yellow nails. In 1966 (3), Emerson described a patient with a pleural eff usion. All nails may be aff ected, but some may be spared (4) . Although there are data claiming that only two groups of symptoms appear in 1/3 of cases (3), the typical clinical picture of YNS (5, 6) is characterized by a triad of yellow nails, lymphedema at one or more sites, and chronic respiratory disease (bronchitis, bronchiectasis and rhinosinusitis) (7 -12) . or varicosity. Other cases have normal lymphatics, indicating that a functional rather than an anatomical defect may be present, or only the smallest lymph vessels are defective (4) .
Respiratory disorders include: sinusitis, recurrent pneumonia, chronic bronchitis, bronchiectasis, pleural eff usion (18) .
It is believed that YNS is caused by lymphatic abnormalities, either anatomical (found only in a minority of patients with congenital abnormalities), or functional, with increased microvascular permeability (19) . A dense fi brous tissue has been found in the nail bed and matrix, replacing subungual stroma with scattered ectatic vessels; obstruction of lymphatics by this dense stroma may be responsible for the abnormal lymphatic function found in the aff ected digits in some but not all cases (4) . Reduced lymphatic drainage may cause peripheral edema or pleural eff usion (13, 16) .
Case report
Th e case history of a 47-year-old female textile worker shows that she presented with nail changes at the age of 40. Her nails stopped growing and became dark in color. Antifungal therapy provided some improvement. Two years later, at the age of 42, she had pneumonia and since the age of 43 she suff ers from chronic obstructive bronchitis. She also developed edema of both legs, expressed especially in the morning, followed by numbness of fi ngers. Since the age of 45, in the last two years, all her nails have been discolored, yellow to yellow-gray, thickened, ingrown, painful, and almost stopped growing. Due to leg edema she was treated at the Institute of Rheumatology in Belgrade with the diagnosis: polyarthralgia and edema of talocrural joints of both legs. Her family history was negative.
Physical examination
Skin examination showed yellowish to gray nails; the nail plates were thickened, separated from the nail bed, without lunula and cuticle, laterally ingrown in the perionychium (tweezer look), accompanied by pain (Figures 1 and 2 ). Lower extremities, ankles and feet were aff ected with edema: elastic edema, without skin discoloration (Figure 3 ). Chest and heart X-ray: slightly prominent bilateral hilar-basal shadows; the cardiac silhouette was normal in size and contour.
Laboratory and other test results
Spirometry -spirogram: mild obstructive pulmonary insuffi ciency.
Bronchial provocation test with methacholine: negative. Pulmonary perfusion scintigraphy: no clear scintigraphic signs of perfusion abnormalities.
Skin prick testing to aeroallergens: positive to grass pollen and textile dust.
Pulmonary fi ndings -diagnosis: chronic obstructive bronchitis, bronchial asthma.
ENT fi ndings -diagnosis: chronic rhinitis, 
Th erapy
In addition to the medications prescribed by the pulmologist and cardiologist, vitamin E capsules (200 mg 3 times a day), topical vitamin E solution, and AD drops were initiated. Several months later, the treatment showed improvement: the nails started growing, the bilateral nasal polyposis, bilateral cochlear nerve lesions.
Ophthalmology fi ndings -diagnosis: traumatic cataract of the left eye, concomitant strabismus.
Cardiovascular examination -diagnosis: labile arterial hypertension.
proximal parts of nail plates were of normal color, and the lunula became visible.
On follow-up examination, after 15 months of treatment, the nail plates on the hands were yellowish in the distal portion, from 1 to several millimeters ( Figure  4) . Th e toenail plates were thickened, yellowish-brown in the distal portion, from 1mm to involvement of the whole thumb nail plate; the proximal nail plates were normal ( Figure 5) ; the lower legs, ankles and feet were swollen, aff ected by lymphedema ( Figure 6 ).
Discussion
According to the literature data, up to 2004, there were 150 case reports on YNS (17), by 2014, about 200 cases were described (1), confi rming that it is an extremely rare disease.
Th e syndrome aff ects all age groups: from birth to old age (20, 21, 22) : Valdés et al. reviewed reports on 150 patients aged 0 to 88 years, with a median age of 60 years (range from 41 to 80 years) (12) . Th e literature data show that the disorder is more common in females, with a female to male ration of 1.6 : 1 (10, 23, 24) . In their study, Valdés et al. reported a male to female ratio of 1.2 : 1 (12). According to the world literature, only a small number of reports have been published on YNS in children (8, 25 -28) ; congenital cases have been reported as well (28, 29) .
According to Valdés and associates (12), lymphedema was observed in all patients, nail discoloration in 85.6%, and pleural eff usion in 68.3%, while other authors claim that nail discoloration was registered in 89% of patients, lymphedema in 80%, and respiratory disease in a 63% (25, 28, 30) . Th ere is a case report of a girl with lymphedema and pleural eff usion, without nail discoloration (8), a boy only with nail discoloration (28) , and a female patient who had yellow nails since childhood, without lymphedema, who postpartum developed a massive pleural eff usion (21) . Our patient exhibited a clinical triad of nail discoloration, lymphedema, and a respiratory disease. Nail discolorations may precede other symptoms, as in our case, may appear at the same time, or later (14) . All nails are aff ected only in 10% of cases (9) . Th e nail growth is always slow, 0.1 to 0.25 mm per week, instead of 0.5 to 2 mm per week (4, 14) . In our patient nail discoloration started before other manifestations of the triad, but it fully developed later.
Th ere are opinions that YNS is a hereditary disorder, transmitted in an autosomal dominant fashion (31) . Although congenital hypoplasia of the lymphatics plays an important role in the clinical picture (10), in a series of 150 patients (12), familial YNS was registered only in 9 patients. Due to low incidence of familial cases (32) , it has generally been accepted that YNS is not primarily a genetic, but a sporadic (20) , acquired disorder (16) . It may be idiopathic or secondary to systemic diseases, or a result of adverse drug eff ects (6, 33) . Th e pathology of YNS is not known (28) . Firstly, hypoplastic or deficient lymphatic vessels have been postulated as the cause; it has been hypothesized that the clinical manifestations of YNS are the result of primary stromal sclerosis, which may lead to lymphatic obstruction. Lymphangiography has demonstrated anatomic defects in both the number and size of the lymphatic vasculature of some, but not all patients, as mentioned before. Th e reversibility of YNS and the lack of demonstrable anatomic defects in some patients suggest that the underlying cause of this condition may be a functional rather than an anatomic abnormality. It is assumed that the respiratory component of the disease is caused either by lymphatic system hypoplasia or the immune defi ciency (34) . YNS can be associated with combined immune defi ciency, which may be responsible for associated sinopulmonary infections manifestations (20) .
YNS has been associated with a variety of diseases (17) . Th e most common conditions associated with YNS include malignant diseases -melanoma (3), bronchogenic carcinoma (35) , thoracic carcinoma (36) renal cell carcinoma (37); lymphproliferative diseases (38, 39) ; immune defi ciency conditions (39), acquired immunodefi ciency syndrome (40); endocrine diseases (25, 40, 41, 42) ; connective tissue diseases (10, 43, 44) ; obstructive sleep apnea (45); xanthogranulomatous pyelonephritis (46) , nephrotic syndrome (47), membranous glomerulonephritis (24), tuberculosis (48) post-myocardial infarction (49), pericardial eff usion (50), asthma (42) . YNS has been reported after treatment with sodium valproate, D-penicillamine (51), and gold sodium thiomalate in the treatment of rheumatoid arthritis (52).
Valdés and associates (12) studied reports of 150 patients, out of which 14 presented with malignancy. Th ere are opinions that YNS should be examined in terms of neoplasia (52) , even some claiming that it is a paraneoplastic disease (53) .
Clues to diagnosis are the presence of dystrophic, yellowish nails, peripheral lymphedema and pleural eff usions (54) . Nail changes are of greatest diagnostic signifi cance; they should be distinguished from changes found in lichen planus, which is not associated with systemic symptoms, whereas changes on the nail plates are characteristically followed by atrophy (especially visible on the nails on the hands), which is not the case in YNS (4) . Some authors believe that the appearance of yellow nails in hypothyroidism and in acquired immune defi ciency syndrome (AIDS) is solely the result of slow nail growth (40) . Diff erential diagnosis should include systemic edemas, as well as long-term pleural eff usions in patients with bronchiectasis and sinusitis (54) .
Apart from adequate treatment of recurrent infections, pleural eff usion and associated diseases, André (55) recommends the following treatment of nail changes: intradermal triamcinolone acetonide injections, topical application of vitamin E in DMSO (dimethyl sulphoxide), oral vitamin E -400 -800 IU/day during 18 months, and zinc sulphate -300 mg/day for 2 years, in combination with antimycotics, if necessary (55) . Itraconazole increases the longitudinal growth rate of nail plates (4) . Th e combination of vitamin E and antimycotics, (itraconazole or fl uconazole) in secondary infection, has led to signifi cant improvement. Douri (29) also reported about benefi cial eff ects of vitamin E in the treatment of this disorder. After 6 months of treatment with vitamin E solution, Lambert reported an improvement of fi ngernail growth rate, but not signifi cant compared to placebo (28) . Th e assumed mechanisms of favorable eff ects of vitamin E are based on its antioxidant eff ects in vivo, which play an important role in cell membranes protection from oxidative damage by free radicals, in blocking the production of yellow pigment lipofuscin (pigment resulting from lipid oxidation of free radicals, causing diff erent degrees of yellow color in tissues) and in prevention of the DNA and other cellular proteins damage, which may disturb the keratinization process and decrease the growth rate of nails (56) .
Our patient presented with a classic triad of YNS: yellow nails, lymphedema and respiratory disorders. Th e fi rst changes appeared on the nails, then respiratory disorders, and fi nally lymphedema. After consulting a pulmonologist, she received treatment for respiratory problems. Topical and oral vitamin E therapy resulted in improvement in terms of nail growth rate without yellow discoloration.
Th e course of the disease is generally benign, and clinical manifestations are usually managed with the above mentioned therapy (17) . Spontaneous improvement of nail discoloration is reported in up to 30% of cases (6, 46) .
Conclusion
We report a rare case of yellow nail syndrome where all the nails were aff ected, with a recognized association with chronic pulmonary disease and edema of the legs, and favorable response to systemic and topical vitamin E treatment.
